Clinical Trial Update: Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA) [Phase 3]

View source ↗

Summary

This clinical trial update reports on a Phase 3 study of VDPHL01 for use in females with androgenetic alopecia (AGA). Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• VDPHL01

Snippet

Sponsor: Veradermics, Inc. | Conditions: Androgenetic Alopecia (AGA), Androgenetic Alopecia | Phase 3 | Status: RECRUITING